<< Back to News

System Formulary Update
Quizartinib (Vanflyta)

Situation:

Quizartinib (Vanflyta) 17.7 mg and 26.5 mg tablets were approved for addition to the health system formulary at the January 2024 System Pharmacy and Therapeutics Commitee meeting

Background:

The following medications were reviewed: Quizartinib (Vanflyta) 17.7 mg and 26.5 mg tablets

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary:

• Quizartinib (Vanflyta) 17.7 mg and 26.5 mg tablets

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, February 13, 2024